Tenosynovial Giant Cell Tumor of Foot in a Patient with Radioiodine-Refractory Thyroid Cancer: Imaging Findings on FDG-PET/CT, MRI, and Radioiodine Scan
Abstract: We herein illustrate a case of benign tenosynovial giant cell tumor, which was incidentally detected as FDG-avid lesion on PET/CT in a patient with radioiodine refractory thyroid cancer, with predominantly non-iodine concentrating disease. The lesion was followed up clinically and with local MRI annually for subsequent 3 years. The utility of hybrid PET-CT imaging, the non-iodine concentration of the tumor along with clinical knowledge, and findings on other imaging and pathological modalities in answering and diagnosing incidental benign musculoskeletal tumors in a patient with known thyroid malignancy are presented here.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Tenosynovial Giant Cell Tumor of Foot in a Patient with Radioiodine-Refractory Thyroid Cancer: Imaging Findings on FDG-PET/CT, MRI, and Radioiodine Scan ; day:20 ; month:12 ; year:2022
World Journal of Nuclear Medicine ; (20.12.2022)
- Beteiligte Personen und Organisationen
-
Loharkar, Sarvesh
Basu, Sandip
- DOI
-
10.1055/s-0042-1758804
- URN
-
urn:nbn:de:101:1-2023020211502212092699
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Loharkar, Sarvesh
- Basu, Sandip
Ähnliche Objekte (12)
Progressive Unilateral Proptosis and (18F) FDG-Avid Lesions Connoting Aggressive Disease in Radioiodine-Refractory Differentiated Thyroid Carcinoma
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Radioiodine Remnant Ablation: A Critical Review
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features
Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report
Clinico-pathological factors and [18F]FDG PET/CT metabolic parameters for prediction of progression-free survival in radioiodine refractory differentiated thyroid carcinoma
Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma
Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma
Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study
Progressive Unilateral Proptosis and (18F) FDG-Avid Lesions Connoting Aggressive Disease in Radioiodine-Refractory Differentiated Thyroid Carcinoma
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Radioiodine Remnant Ablation: A Critical Review
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features
Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report
Clinico-pathological factors and [18F]FDG PET/CT metabolic parameters for prediction of progression-free survival in radioiodine refractory differentiated thyroid carcinoma
Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma
Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma
Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study
Progressive Unilateral Proptosis and (18F) FDG-Avid Lesions Connoting Aggressive Disease in Radioiodine-Refractory Differentiated Thyroid Carcinoma
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Radioiodine Remnant Ablation: A Critical Review
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features
Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report
Clinico-pathological factors and [18F]FDG PET/CT metabolic parameters for prediction of progression-free survival in radioiodine refractory differentiated thyroid carcinoma
Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma
Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma
Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma